Published Paper Details:

This review of literature upgrades about the unanticipated surge of mucormycosis or black fungus during the outbreak of the second wave of Covid-19. The emergency of this uncommon disease was described as Covid Associated Mucormycosis (CAM) which was caused due to fungi mucormycetes or zygomycosis. This infection emerged as a threat to patients who were recovering from corona virus and additional risk factors that contributed to this disease were diabetes, extended stay in ICU, organ and stem transplant, kidney dysfunction, use of broad-spectrum antibiotics etc. Symptoms vary depending on the area of the body being affected and that includes headache, coughing, distress, deprivation of sensation, etc. This manuscript provides a fleeting overview on various forms of mucormycosis, its epidemiology, pathogenesis and treatment that is divided into three stages as first line therapy, salvage therapy and lastly surgical therapy. The treatment included amphotericin B as primary treatment followed by posaconazole, itraconazole, and isavuconazole and the surgical debridement in case of deep infected tissues. In conclusion, it necessitates comprehensive understanding and timely management of the mucormycosis to treat it effectively.